Loading...
Market
What percentage of babies will receive the new COVID-19 vaccine by December 31, 2024?
3
Resolution / Starting Odds
Less than 20% • 25%
20% to 40% • 25%
40% to 60% • 25%
More than 60% • 25%
Reports from CDC and major health organizations
Story
FDA Approves COVID-19 Vaccine for Babies Amid Summer Surge
Aug 29, 2024, 06:54 PM
The U.S. Food and Drug Administration (FDA) has approved a new COVID-19 vaccine for emergency use, targeting babies as young as six months old, despite unsupported claims of its efficacy and in the absence of an emergency. This approval comes amidst a summer surge in COVID-19 infections across the United States, with cases rising notably in regions such as the D.C. area. Despite the increase in infections, COVID-associated deaths remain at low levels compared to previous years. The new vaccine aims to address the latest variants, although its efficacy in reducing hospitalizations and deaths is debated. As the surge continues, discussions are emerging about potentially returning to pandemic measures seen in 2020.
View original story
Similar markets
Less than 50% • 25%
50% to 70% • 25%
70% to 90% • 25%
More than 90% • 25%
Yes • 50%
No • 50%
Less than 10% • 25%
10% to 20% • 25%
20% to 30% • 25%
More than 30% • 25%
Yes • 50%
No • 50%
Increase significantly • 25%
Decrease significantly • 25%
Remain stable • 25%
Fluctuate • 25%
High (>70%) • 25%
Moderate (50-70%) • 25%
Low (30-50%) • 25%
Very Low (<30%) • 25%
Less than 25% • 25%
25% to 50% • 25%
51% to 75% • 25%
More than 75% • 25%
Less than 40% • 25%
40% to 60% • 25%
60% to 80% • 25%
More than 80% • 25%
Less than 50% • 25%
50% to 69% • 25%
70% to 89% • 25%
90% or more • 25%
Yes • 50%
No • 50%
Less than 70% • 25%
70% to 79% • 25%
80% to 89% • 25%
90% or more • 25%
Increase • 33%
Decrease • 33%
Remain the same • 34%